EUVIMEDEUVIMED entdecken
Crossref

A liposomal radionanoformulation for targeted drug delivery and real time monitoring by radionuclide imaging for HER2 overexpressing cancers

Shishu Kant Suman, Archana Mukherjee iD, Rohit Kumar Sharma

Drug Development Research · 2023

DOI: 10.1002/ddr.22106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2023. Verfasst von Shishu Kant Suman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai, India. Hauptthemen laut MEDLINE: Liposomes, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Department of Atomic Energy, Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liposomal formulations carrying chemotherapeutic drugs have demonstrated great potential as effective drug delivery systems. Smart nanoformulations decorated with targeting agents and probes are desired for site specific delivery of drugs and real time monitoring. In this study, we aimed to develop liposomal formulation loaded with doxorubicin and tagged with trastuzumab antibody (Ab) for targeting human epidermal growth factor receptor 2 (HER2) positive tumors. Liposomes were prepared by ethanol injection method using modified lipids to conjugate trastuzumab and radiolabel with Tc‐99m radioisotope using DTPA for imaging by single photon emission computed tomography (SPECT). Doxorubicin was loaded using the active pH gradient method. The conjugation of Ab to liposomes was validated by SDS‐PAGE and MALDI‐MS. 99m Tc labeled liposomes encapsulating doxorubicin conjugated with antibody ( 99m Tc‐Lip‐Ab‐Dox) and 99m Tc labeled liposomes encapsulating doxorubicin ( 99m Tc‐Lip‐Dox) were found to be stable in blood plasma and saline using chromatography method. The specificity of 99m Tc‐Lip‐Ab‐Dox against HER2 receptor was evident from cell uptake and inhibition studies. Results also corroborated with confocal microscopy studies. In vivo studies in tumor bearing severe combined immunodeficient mice by SPECT imaging and biodistribution studies revealed higher uptake of 99m Tc‐Lip‐Ab‐Dox in tumor and less accumulation in the liver compared to 99m Tc‐Lip‐Dox. In conclusion, liposomal nanoformulation for immunotargeting and monitoring of drug delivery was successfully formulated and evaluated. Encouraging results in preclinical studies were obtained with the radioformulation. Such smart radioformulations will not only serve the purpose of site‐specific controlled release of drugs at the target site but also aid in optimizing the drug doses and schedule of cancer treatment by monitoring pharmacokinetics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesNeoplasmsMiceAnimalsHumansTissue DistributionDrug Delivery SystemsDoxorubicinTomography, Emission-Computed, Single-PhotonTrastuzumab

Stichwörter der Autor:innen

drug deliveryimmunotargeted drug deliverynanoformulationsradiolabeled liposomesradionuclide imagingtheranostics

Substanzen

LiposomesDoxorubicinTrastuzumab

Autor:innen und Institutionen

  • Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai, India.
  • Homi Bhabha National Institute, Mumbai, India.
  • Department of Chemistry and Centre of Advanced Studies, Panjab University, Chandigarh, India.

ORCID-Profile: Archana Mukherjee

Förderung

  • Department of Atomic Energy, Government of India

Zitieren

APA

Suman, S. K., Mukherjee, A., & Sharma, R. K. (2023). A liposomal radionanoformulation for targeted drug delivery and real time monitoring by radionuclide imaging for HER2 overexpressing cancers. Drug Development Research. https://doi.org/10.1002/ddr.22106

Vancouver

Suman SK, Mukherjee A, Sharma RK. A liposomal radionanoformulation for targeted drug delivery and real time monitoring by radionuclide imaging for HER2 overexpressing cancers. Drug Development Research. 2023. doi:10.1002/ddr.22106

BibTeX
@article{Suman2023,
  author = {Suman, Shishu Kant and Mukherjee, Archana and Sharma, Rohit Kumar},
  title = {A liposomal radionanoformulation for targeted drug delivery and real time monitoring by radionuclide imaging for HER2 overexpressing cancers},
  journal = {Drug Development Research},
  year = {2023},
  doi = {10.1002/ddr.22106}
}
Kostenlos starten →